RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Mesothelial Neoplasms
Accession: DOID:9002899
browse the term
Definition: Neoplasms composed of tissue of the mesothelium, the layer of flat cells, derived from the mesoderm, which lines the body cavity of the embryo. In the adult it forms the simple squamous epithelium which covers all true serous membranes (peritoneum, pericardium, pleura). The concept does not refer to neoplasms located in these organs. (From Dorland, 27th ed)
Synonyms: exact_synonym: Mesothelial Neoplasm
primary_id: MESH:D018301
alt_id: RDO:0006122
xref: EFO:1001044
G
Msln
mesothelin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20371980 PMID:21984916
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
G
Traf7
TNF receptor associated factor 7
ISO
DNA:missense mutations:multiple
RGD
PMID:29148537
RGD:151356962
NCBI chr10:13,533,570...13,552,290
Ensembl chr10:13,533,570...13,552,203
G
Acvr1b
activin A receptor type 1B
ameliorates
ISO
RGD
PMID:30061637
RGD:151665492
NCBI chr 7:132,286,266...132,329,679
Ensembl chr 7:132,286,275...132,329,673
G
Ada
adenosine deaminase
treatment
ISO
RGD
PMID:17952507
RGD:152995277
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Adamts2
ADAM metallopeptidase with thrombospondin type 1 motif, 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26139392
NCBI chr10:34,920,992...35,126,465
Ensembl chr10:34,921,049...35,123,821
G
Ago1
argonaute RISC component 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 5:138,722,111...138,757,118
Ensembl chr 5:138,722,111...138,773,546
G
Ago2
argonaute RISC catalytic component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 7:105,018,202...105,105,118
Ensembl chr 7:105,029,120...105,104,974
G
Anxa2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20682992
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Apoa1
apolipoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Bap1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24928783 PMID:25231345 PMID:26463840 PMID:26928227 PMID:29112861 PMID:24928783 More...
RGD:9586039
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
G
Bcl10
BCL10, immune signaling adaptor
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Mesothelioma, malignant | ClinVar Annotator: match by term: Mesothelioma, somatic
OMIM CTD ClinVar
PMID:9989495 PMID:10380920 PMID:10408400 PMID:25741868 PMID:28492532
NCBI chr 2:234,840,880...234,850,520
Ensembl chr 2:234,840,858...234,850,523
G
Bcl2
BCL2, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16850164
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
C9
complement C9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
G
Calb2
calbindin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438
G
Ccl27
C-C motif chemokine ligand 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 5:56,941,402...56,948,511
Ensembl chr 5:56,941,402...56,948,506
G
Ccl3
C-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl5
C-C motif chemokine ligand 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccl7
C-C motif chemokine ligand 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,016,446...67,018,303
G
Ccne2
cyclin E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:24,284,922...24,297,632
G
Cd40
CD40 molecule
treatment
ISO
RGD
PMID:22002241
RGD:11522742
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cdh5
cadherin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
G
Cdk6
cyclin-dependent kinase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:30,646,460...30,829,634
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11453316
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19223589 PMID:21526190 PMID:29112861 PMID:37441092
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
G
Cfap45
cilia and flagella associated protein 45
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr13:84,989,474...85,012,880
Ensembl chr13:84,981,728...85,012,878
G
Cldn10
claudin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr15:95,862,785...95,954,526
Ensembl chr15:95,862,760...95,954,526
G
Cldn15
claudin 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr12:19,698,167...19,708,419
Ensembl chr12:19,698,337...19,706,819
G
Cldn4
claudin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
G
Cldn5
claudin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
G
Cldn8
claudin 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr11:27,875,857...27,878,106
Ensembl chr11:27,875,692...27,878,513
G
Clec11a
C-type lectin domain containing 11A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 1:94,800,456...94,809,002
Ensembl chr 1:94,801,496...94,804,633
G
Col12a1
collagen type XII alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 8:80,547,592...80,665,665
Ensembl chr 8:80,547,593...80,665,686
G
Copg1
COPI coat complex subunit gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26463840
NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616
G
Csf1
colony stimulating factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Cxcl12
C-X-C motif chemokine ligand 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl13
C-X-C motif chemokine ligand 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Ddx3x
DEAD-box helicase 3, X-linked
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr X:9,479,532...9,493,169
Ensembl chr X:9,479,532...9,493,168
G
Ddx51
DEAD-box helicase 51
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr12:46,011,303...46,015,989
Ensembl chr12:46,011,070...46,016,200
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27032653
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27032653
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Enox2
ecto-NOX disulfide-thiol exchanger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26807072
NCBI chr X:128,270,941...128,593,074
Ensembl chr X:128,271,074...128,593,039
G
Ephx1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16697254
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:92,714,315...92,790,235
G
F9
coagulation factor IX
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr X:138,352,334...138,396,835
Ensembl chr X:138,352,298...138,396,835
G
Fgd6
FYVE, RhoGEF and PH domain containing 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 7:28,597,609...28,712,908
Ensembl chr 7:28,597,609...28,712,456
G
Fgf18
fibroblast growth factor 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr10:18,210,240...18,241,929
Ensembl chr10:17,706,174...17,736,818
G
Fgf9
fibroblast growth factor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
G
Fn1
fibronectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fth1
ferritin heavy chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26818092
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Gpr27
G protein-coupled receptor 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 4:132,328,364...132,329,497
Ensembl chr 4:132,328,364...132,329,497
G
Gpr37
G protein-coupled receptor 37
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 4:54,138,860...54,160,927
Ensembl chr 4:54,138,870...54,161,001
G
Gstm1
glutathione S-transferase mu 1
ISO
DNA:deletion:cds (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16697254 PMID:7606714
RGD:7495814
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Hdac4
histone deacetylase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
G
Heph
hephaestin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26818092
NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:18,677,101...18,745,409
G
Htra1
HtrA serine peptidase 1
disease_progression
ISO
protein:increased expression:mesothelium (human)
RGD
PMID:18681782
RGD:152975625
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
G
Icam2
intercellular adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr10:91,308,608...91,319,536
Ensembl chr10:91,308,538...91,315,293
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Igf2bp3
insulin-like growth factor 2 mRNA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23621518
NCBI chr 4:78,060,494...78,195,007
Ensembl chr 4:78,060,494...78,194,865
G
Il12b
interleukin 12B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:28,893,008...28,902,903
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il2ra
interleukin 2 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il3
interleukin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
G
Il4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Ilk
integrin-linked kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23045294
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
G
Kat5
lysine acetyltransferase 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26780987
NCBI chr 1:202,895,751...202,903,178
Ensembl chr 1:202,895,751...202,903,458
G
Kit
KIT proto-oncogene receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,548,877...32,624,652
G
Limch1
LIM and calponin homology domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr14:41,112,579...41,425,001
Ensembl chr14:41,114,803...41,425,191
G
Lta
lymphotoxin alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Mcam
melanoma cell adhesion molecule
disease_progression
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22784439 PMID:23621518 PMID:23621518
RGD:7364782
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Mdk
midkine
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:77,901,158...77,903,130
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:45,790,791...45,897,876
G
Mif
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
G
Mir125a
microRNA 125a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 1:58,677,626...58,677,710
Ensembl chr 1:58,677,626...58,677,710
G
Mir126a
microRNA 126a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21483773
NCBI chr 3:9,415,063...9,415,180
Ensembl chr 3:9,415,063...9,415,180
G
Mir32
microRNA 32
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27716620
NCBI chr 5:71,596,083...71,596,152
Ensembl chr 5:71,596,083...71,596,152
G
Mir484
microRNA 484
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr10:887,684...887,760
Ensembl chr10:887,684...887,760
G
Mlana
melan-A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr 1:227,469,537...227,483,343
Ensembl chr 1:227,469,537...227,483,343
G
Msln
mesothelin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19190155 PMID:27032653
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
G
Mtmr4
myotubularin related protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr10:72,393,411...72,416,342
Ensembl chr10:72,392,551...72,416,342
G
Muc1
mucin 1, cell surface associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Nanos1
nanos C2HC-type zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 1:259,897,663...259,901,561
Ensembl chr 1:259,897,939...259,898,730
G
Nat2
N-acetyltransferase 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16697254 PMID:15993904
RGD:5131858
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Nf2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23435014 PMID:26463840 PMID:26678224 PMID:26928227 PMID:29112861 PMID:37441092 PMID:32271879 PMID:16166281 More...
RGD:150530636 , RGD:150530640
NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
G
Ngf
nerve growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25162674
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Osmr
oncostatin M receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 2:55,907,119...55,961,373
Ensembl chr 2:55,907,132...55,961,262
G
Parp1
poly (ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21543585
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pdpn
podoplanin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr 5:155,601,691...155,635,656
Ensembl chr 5:155,601,691...155,635,656
G
Pllp
plasmolipin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr19:10,315,104...10,335,892
Ensembl chr19:10,315,104...10,335,892
G
Ptprf
protein tyrosine phosphatase, receptor type, F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 5:131,741,959...131,824,000
Ensembl chr 5:131,742,754...131,810,023
G
Pycard
PYD and CARD domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26935421
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:148,679,530...148,740,317
G
Rxra
retinoid X receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Ryr2
ryanodine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr17:58,389,925...58,975,641
Ensembl chr17:58,389,925...58,975,142
G
S100b
S100 calcium binding protein B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,881...12,394,743
G
Sdc1
syndecan 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27032653
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
G
Sema4f
semaphorin 4F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 4:115,411,411...115,437,721
Ensembl chr 4:115,411,417...115,437,721
G
Serpina4
serpin family A member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr 6:122,999,970...123,009,083
Ensembl chr 6:122,999,900...123,009,082
G
Setd2
SET domain containing 2, histone lysine methyltransferase
ISO
CTD Direct Evidence: marker/mechanism DNA:mutations:multiple (human)
CTD RGD
PMID:26928227 PMID:27834213
RGD:150429641
NCBI chr 8:110,511,808...110,597,475
Ensembl chr 8:110,511,772...110,597,489
G
Setdb1
SET domain bifurcated histone lysine methyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr 2:182,898,738...182,930,283
Ensembl chr 2:182,898,738...182,930,506
G
Sf3b1
splicing factor 3b, subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr 9:56,492,403...56,532,300
Ensembl chr 9:56,492,403...56,532,300
G
Shbg
sex hormone binding globulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28377727
NCBI chr10:54,831,716...54,849,162
Ensembl chr10:54,332,941...54,351,057
G
Slc22a5
solute carrier family 22 member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr10:38,509,072...38,536,240
Ensembl chr10:38,008,311...38,035,309
G
Slc2a1
solute carrier family 2 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Smarca2
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 1:224,191,125...224,358,640
Ensembl chr 1:224,191,125...224,358,684
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20617513
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Tbl1xr1
TBL1X/Y related 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 2:104,788,950...104,929,055
Ensembl chr 2:104,801,721...104,929,055
G
Tf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26818092
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tfdp2
transcription factor Dp-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr 8:96,760,459...96,901,466
Ensembl chr 8:96,760,504...96,896,682
G
Tgfb2
transforming growth factor, beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:98,160,087...98,261,405
G
Tnfrsf8
TNF receptor superfamily member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23056237
NCBI chr 5:157,123,183...157,168,421
Ensembl chr 5:157,123,185...157,168,421
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227 PMID:37441092
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Traf7
TNF receptor associated factor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr10:13,533,570...13,552,290
Ensembl chr10:13,533,570...13,552,203
G
Txn1
thioredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27032653
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629
G
Ulk2
unc-51 like autophagy activating kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26928227
NCBI chr10:46,451,578...46,530,462
Ensembl chr10:46,454,030...46,530,407
G
Vim
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22784439
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Wnt3
Wnt family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr10:88,680,198...88,724,170
Ensembl chr10:88,680,248...88,724,099
G
Wt1
WT1 transcription factor
ISO
ClinVar Annotator: match by term: Mesothelioma, malignant CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:1302008 PMID:1327525 PMID:1338906 PMID:1655284 PMID:1658787 PMID:6307071 PMID:8621495 PMID:9090524 PMID:9398852 PMID:9475094 PMID:9499425 PMID:9529364 PMID:9536098 PMID:9607189 PMID:9745866 PMID:10094551 PMID:10505699 PMID:10561752 PMID:10670748 PMID:10762296 PMID:10792605 PMID:11007843 PMID:11182928 PMID:12050205 PMID:12640141 PMID:12970737 PMID:15150775 PMID:15509792 PMID:16439601 PMID:16987884 PMID:17496156 PMID:17541636 PMID:17576681 PMID:17694336 PMID:17853480 PMID:19484379 PMID:20442690 PMID:21499692 PMID:21508141 PMID:22099579 PMID:22784439 PMID:22815844 PMID:22908070 PMID:23295293 PMID:23302619 PMID:23349334 PMID:23497137 PMID:23515051 PMID:23715653 PMID:24033266 PMID:24161391 PMID:24856380 PMID:25349199 PMID:25501161 PMID:25623218 PMID:25741868 PMID:25813279 PMID:25818337 PMID:26069768 PMID:26248470 PMID:26467025 PMID:27719739 PMID:28204945 PMID:28492532 PMID:28780565 PMID:28811308 PMID:29474669 PMID:29668062 PMID:29869118 PMID:30406062 PMID:30655312 PMID:30963316 PMID:31970404 PMID:32352694 PMID:32493750 PMID:32581362 PMID:32604935 PMID:32891756 PMID:33742552 PMID:34386660 PMID:34490048 PMID:34622098 PMID:35211794 PMID:35904974 PMID:36110220 PMID:36245711 PMID:36964972 PMID:36980135 More...
NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643
G
Wwc1
WW and C2 domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25756049
NCBI chr10:20,300,735...20,454,393
Ensembl chr10:20,300,833...20,454,497
G
Xrcc1
X-ray repair cross complementing 1
treatment
ISO
RGD
PMID:22982660
RGD:151347428
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Bap1
BRCA1 associated deubiquitinase 1
disease_progression
ISO
RGD
PMID:27422796
RGD:127229946
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
G
Birc5
baculoviral IAP repeat-containing 5
exacerbates
ISO
mRNA:increased expression:pleura, lung (human)
RGD
PMID:17253596
RGD:153344528
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Birc7
baculoviral IAP repeat-containing 7
ameliorates
ISO
mRNA:increased expression:pleura, lung (human)
RGD
PMID:17253596
RGD:153344528
NCBI chr 3:168,047,824...168,052,606
Ensembl chr 3:168,047,824...168,052,606
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
ameliorates
ISO
RGD
PMID:18722110
RGD:151667912
NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:116,714,711...116,837,240
G
Csf1r
colony stimulating factor 1 receptor
ISO
mRNA:increased expression:peritoneum�� (human)
RGD
PMID:24722292
RGD:150524278
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Emx2
empty spiracles homeobox 2
exacerbates
ISO
mRNA:decreased expression:mesothelium of pleural cavity (human)
RGD
PMID:25023662
RGD:153323312
NCBI chr 1:258,626,584...258,633,594
Ensembl chr 1:258,626,584...258,633,594
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
disease_progression
ISO
mRNA, protein:increased expression:pleura
RGD
PMID:22028491
RGD:126781718
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
Il7r
interleukin 7 receptor
disease_progression
ISO
RGD
PMID:26155428
RGD:151347688
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
Kdm6a
lysine demethylase 6A
ISO
mRNA:increased expression:mesothelium of pleural cavity (human)
RGD
PMID:28197626
RGD:150429737
NCBI chr X:4,337,466...4,477,100
Ensembl chr X:4,337,750...4,477,062
G
Mir192
microRNA 192
ISO
miRNA:decreased expression:pleura (human)
RGD
PMID:26125439
RGD:11529530
NCBI chr 1:203,564,946...203,565,055
Ensembl chr 1:203,564,946...203,565,055
G
Mir193a
microRNA 193a
ISO
miRNA:decreased expression:pleura (human)
RGD
PMID:26125439
RGD:11529530
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
G
Mir200b
microRNA 200b
ISO
miRNA:decreased expression:pleura (human)
RGD
PMID:26125439
RGD:11529530
NCBI chr 5:166,649,272...166,649,366
Ensembl chr 5:166,649,272...166,649,366
G
Mlh1
mutL homolog 1
disease_progression
ISO
RGD
PMID:23810210
RGD:126848799
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
G
Ncoa2
nuclear receptor coactivator 2
ameliorates
ISO
protein:increased expression:mesothelium of pleural cavity (human)
RGD
PMID:22011668
RGD:153002578
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
G
Nf2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
disease_progression
ISO
DNA:loss of heterozygosity
RGD
PMID:27378628 PMID:26928227 PMID:26493618
RGD:150530638 , RGD:150429647 , RGD:11553131
NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
G
Rad21
RAD21 cohesin complex component
ISO
RGD
PMID:19380173
RGD:150520037
NCBI chr 7:83,287,867...83,314,810
Ensembl chr 7:83,287,870...83,314,817
G
Setd2
SET domain containing 2, histone lysine methyltransferase
disease_progression
ISO
DNA:mutations:CDS:multiple (human)
RGD
PMID:26928227 PMID:33691361
RGD:150429647 , RGD:150520202
NCBI chr 8:110,511,808...110,597,475
Ensembl chr 8:110,511,772...110,597,489
G
Slc7a5
solute carrier family 7 member 5
disease_progression
ISO
protein:increased expression:pleura
RGD
PMID:22199264 PMID:24912849
RGD:151361201 , RGD:151660330
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Smo
smoothened, frizzled class receptor
disease_progression
ISO
DNA:missense mutations
RGD
PMID:23379358 PMID:33209614
RGD:150521620 , RGD:150521621
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
G
Xiap
X-linked inhibitor of apoptosis
ameliorates
ISO
mRNA:increased expression:pleura, lung (human)
RGD
PMID:17253596
RGD:153344528
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
G
Apc
APC regulator of WNT signaling pathway
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17659810
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
G
Bap1
BRCA1 associated deubiquitinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21642991 PMID:21874000 PMID:26119930 PMID:26719535
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
G
Bcl10
BCL10, immune signaling adaptor
ISO
ClinVar Annotator: match by term: Mesothelioma
ClinVar
PMID:9989495 PMID:10380920 PMID:10408400
NCBI chr 2:234,840,880...234,850,520
Ensembl chr 2:234,840,858...234,850,523
G
Birc3
baculoviral IAP repeat-containing 3
ameliorates
ISO
mRNA:increased expression:mesothelium (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Birc5
baculoviral IAP repeat-containing 5
exacerbates
ISO
mRNA:increased expression:mesothelium (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11283936
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15639718
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18301454
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISO IAGP
CTD Direct Evidence: marker/mechanism DNA:deletion
CTD RGD
PMID:18379362 PMID:20065947
RGD:7248760
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
IAGP
DNA:deletion
RGD
PMID:20065947
RGD:7248760
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:104,010,680...104,019,050
G
Dio2
iodothyronine deiodinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11425850
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21787763
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Egr1
early growth response 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15878867
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Eid1
EP300 interacting inhibitor of differentiation 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15920167
NCBI chr 3:112,922,961...112,924,680
Ensembl chr 3:112,922,668...112,924,752
G
Ephx1
epoxide hydrolase 1
ISO
RGD
PMID:16697254
RGD:4889125
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:92,714,315...92,790,235
G
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15639718 PMID:17659810 PMID:17659810
RGD:4892302
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Fgf1
fibroblast growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15878867
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
G
Fgf2
fibroblast growth factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15878867
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fhit
fragile histidine triad diadenosine triphosphatase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14569398 PMID:18038314
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
G
Gdf10
growth differentiation factor 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18949431
NCBI chr16:9,237,182...9,250,537
Ensembl chr16:9,237,261...9,249,343
G
Gpc3
glypican 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10656689
NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798
G
Gsn
gelsolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15920167
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
Gstm1
glutathione S-transferase mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17290392
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12768194
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Itln1
intelectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15777968
NCBI chr13:83,932,234...83,958,243
Ensembl chr13:83,948,124...83,958,227
G
Jmjd6
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30619488
NCBI chr10:102,539,935...102,545,986
Ensembl chr10:102,041,120...102,047,182
G
Msln
mesothelin
ISO IEP
protein:increased secretion:body fluid CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11751476 PMID:18394747 PMID:20933535 PMID:17785569 PMID:18505465
RGD:2326062 , RGD:2326046
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
G
Mtor
mechanistic target of rapamycin kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21358348
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Muc1
mucin 1, cell surface associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18454162
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Myo18b
myosin XVIIIb
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17294804
NCBI chr12:43,747,003...43,953,694
Ensembl chr12:43,747,010...43,953,695
G
Nf2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12136076 PMID:12168054 PMID:12802287 PMID:16166281 PMID:16319530 PMID:18835652 More...
NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15920167
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538 Ensembl chr20:78,897,770...78,903,538
G
Pdgfa
platelet derived growth factor subunit A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11415934
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pdgfc
platelet derived growth factor C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15920167
NCBI chr 2:166,316,870...166,493,449
Ensembl chr 2:166,316,803...166,493,433
G
Pgr
progesterone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15639718
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Ppp1r14a
protein phosphatase 1, regulatory (inhibitor) subunit 14A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18835652
NCBI chr 1:84,583,127...84,590,743
Ensembl chr 1:84,586,627...84,590,671
G
Puf60
poly-U binding splicing factor 60
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21435101
NCBI chr 7:107,782,799...107,793,759
Ensembl chr 7:107,782,770...107,794,531
G
Rassf1
Ras association domain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12082623 PMID:15639718
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
G
Slc6a20a
solute carrier family 6 member 20a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17659810
NCBI chr 8:123,282,325...123,322,609
Ensembl chr 8:123,281,472...123,322,573
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9533946 PMID:11283936 PMID:15039138 PMID:17290392
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16221779 PMID:18550471
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Syk
spleen associated tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17659810
NCBI chr17:12,604,615...12,678,437
Ensembl chr17:12,604,619...12,661,410
G
Tnc
tenascin C
disease_progression
ISO
RGD
PMID:12605648 PMID:16928692
RGD:4889571 , RGD:4889612
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:77,375,851...77,460,624
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12151629
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Txnrd1
thioredoxin reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17316382
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Wt1
WT1 transcription factor
ISO
ClinVar Annotator: match by term: Mesothelioma
ClinVar
PMID:4332312 PMID:8298644
NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643
G
Xiap
X-linked inhibitor of apoptosis
ameliorates
ISO
mRNA:increased expression:mesothelium (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
G
Xrcc1
X-ray repair cross complementing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564556 PMID:20705543
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Xrcc3
X-ray repair cross complementing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564556
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
G
Lats1
large tumor suppressor kinase 1
ISO
ClinVar Annotator: match by term: Malignant peritoneal mesothelioma
ClinVar
NCBI chr 1:2,160,411...2,193,640
Ensembl chr 1:2,160,411...2,193,640
G
Lats2
large tumor suppressor kinase 2
ISO
ClinVar Annotator: match by term: Malignant peritoneal mesothelioma
ClinVar
NCBI chr15:31,825,068...31,877,193
Ensembl chr15:31,825,092...31,877,220
G
Mecom
MDS1 and EVI1 complex locus
ISO
ClinVar Annotator: match by term: Malignant peritoneal mesothelioma
ClinVar
NCBI chr 2:112,909,353...113,464,583
Ensembl chr 2:112,909,321...113,464,590
G
Traf7
TNF receptor associated factor 7
ISO
DNA:missense mutations:multiple
RGD
PMID:30171198
RGD:151356964
NCBI chr10:13,533,570...13,552,290
Ensembl chr10:13,533,570...13,552,203
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
IAGP
DNA:deletion
RGD
PMID:20065947
RGD:7248760
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all